Visual acuity and quantitative perimetry (Octopus Program 32) testing
was performed in the acute (<30 days after onset) and convalescent (>3
months after onset) phases of disease in 27 patients with untreated N
AION. Initial group mean acuity and sensitivity loss were compared to
final values using the t test. Proportions of patients demonstrating a
change of >2 lines acuity or >2 dB mean sensitivity were calculated.
Patients were classified as either ''progressive'' (n = 6) or ''stable
'' (n = 21) for purposes of additional subgroup analysis. There was no
significant change in group mean visual acuity or field over time. Ov
erall, significant worsening occurred in 11.1% for visual acuity and 2
2.2% for visual field; improvement occurred in 23.8% for acuity and 24
.0% for field. Of 21 ''stable'' patients, none worsened for acuity and
4.7% showed late worsening of field; 31.3% showed significant improve
ment for acuity and 31.6% for field. No ''progressive'' patients demon
strated worsening or improvement after the initial progressive phase.